At Psych Congress 2025, thought leaders emphasized a shift in psychiatric care from symptom control toward enhancing patient functioning and quality of life. Dr. Julie Carbray, Clinical Professor of Psychiatry and Nursing at the University of Illinois Chicago, discussed incorporating sleep science and digital therapeutics into treatment strategies for depression and ADHD to support whole-person care. Dr. Christoph Correll, Professor of Psychiatry and Molecular Medicine at Zucker School of Medicine, presented data on long-acting subcutaneous therapy for schizophrenia, emphasizing its sustained clinical impact. Collectively, these insights highlight psychiatry’s evolving commitment to evidence-based, patient-centered approaches.

Acute Treatment of Migraine in Adolescents: Real-World Analysis of Remote Electrical Neuromodulation (REN)
Source : https://www.pedneur.com/article/S0887-8994(23)00055-3/fulltext
Nearly 10% of children and adolescents in the United States experience migraine. Pharmacological treatment of migraine in adolescents is limited due to only few FDA approved medications, limited efficacy, or...
Conclusions/Relevance: This real-world analysis demonstrates the persistent efficacy of REN for abortive treatment of migraine in adolescents, extending findings of prior clinical trials in adolescents and real-world studies in adults.
-
Huma Sheikh, CEO, NY Neurology Medicine, PCMay 05, 2023This is great to have alternatives.

Comparison of Migraine Characteristics in Patients With and Without Inflammatory Bowel Disease: A Retrospective Cohort Study - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/36960555/
Migraine with and without aura have increased prevalence in IBD patients. Further study of this topic will be helpful to clarify the prevalence of migraine, establish this population's response to...
Conclusions: Migraine with and without aura have increased prevalence in IBD patients. Further study of this topic will be helpful to clarify the prevalence of migraine, establish this population’s response to treatment, and better understand the reason(s) for a low rate of treatment.
-
Huma Sheikh, CEO, NY Neurology Medicine, PCMay 05, 2023This is a good read.